NeoCura PV
TM
For virus prophylaxis, NeoCura develops prophylactic mRNA vaccines for different viruses. For selected viral antigen targets, NeoCura self-designed mRNA could express related antigens in vitro and in vivo with high efficiency, activating antigen specific humoral and cellular immune response, producing antibodies and memory cells, to achieve a safe and effective virus prophylactic goal.
MRNA vaccine induced immune response
Product Highlights
Self adjuvant effects
Non-cell cultured vaccine products, safer
Low toxicity and no integrating risk
Fast vaccine design